Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,082,674
-$405,232 QoQ
Shares Held
4,263
-30.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#2,942
of 4,664 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Elevated Capital Advisors, LLC holds $4,373,518 across 13 Drug Manufacturers - General names. JNJ ranks #1 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
4,263 | $1,082,674 | |
| 2 | ABBV |
AbbVie Inc.
|
3,945 | $992,719 | |
| 3 | AMGN |
Amgen Inc
|
1,865 | $675,353 | |
| 4 | PFE |
Pfizer Inc
|
21,185 | $510,134 | |
| 5 | LLY |
ELI LILLY & Co
|
382 | $458,182 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,669 | $326,647 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,351 | $302,103 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
97 | $12,254 |
All Filings in JNJ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,082,674 | 4,263 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,487,906 | 6,087 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,606,552 | 7,763 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,177,973 | 6,353 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $741,906 | 4,857 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $805,484 | 4,857 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $719,918 | 4,978 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $605,132 | 3,734 | Shares | Sole | 2024-10-22 | |
| No filing history on record for this holder in this stock. | ||||||